Evidence for an instructive mechanism of de novo methylation in cancer cells

Nature Genetics

Volumn 38, Issue 2, 2006, Pages 149-153

  Keshet, Ilana ^a   Schlesinger, Yeshayahu ^a   Farkash, Shlomit ^a   Rand, Eyal ^a   Hecht, Merav ^a   Segal, Eran ^b   Pikarski, Eli ^a   Young, Richard A ^c   Niveleau, Alain ^d   Cedar, Howard ^a   Simon, Itamar ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b ROCKEFELLER UNIVERSITY   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BIOINFORMATICS; CANCER CELL; CELL STRAIN CACO 2; CELL TYPE; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC ALGORITHM; GENOME ANALYSIS; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CHROMOSOMES; COMPUTATIONAL BIOLOGY; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; MODELS, GENETIC; NEOPLASMS;

MAMMALIA;

EID: 31744433660     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1719     Document Type: Review

References (39)

1. Monk, M., Boubelik, M.& Lehnert, S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99, 371-382 (1987).
2. Kafri, T. et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germline. Genes Dev. 6, 705-714 (1992).
3. Brandeis, M. et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435-438 (1994).
4. Macleod, D., Charlton, J., Mullins, J. & Bird, A.P. Sp1 sites in the mouse Aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8, 2282-2292 (1994).
5. Lock, L.F., Takagi, N. & Martin, G.R. Methylation of the HPRT gene on the inactive X occurs after chromosome inactivation. Cell 48, 39-46 (1987).
6. Gidekel, S. & Bergman, Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277, 34521-34530 (2002).
7. Robertson, K.D. & Wolffe, A.P. DNA methylation in health and disease. Nat. Rev. Genet. 1, 11-19 (2000).
8. Baylin, S.B. & Herman, J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168-174 (2000).
9. Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nat. Genet. 21, 163-167 (1999).
10. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002).
11. Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132-138 (2000).
12. Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453-458 (2002).
13. Yu, L. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37, 265-274 (2005).
14. Issa, J.P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988-993 (2004).
15. Chan, A.O. et al. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 160, 1823-1830 (2002).
16. Toyota, M. et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438-5442 (1999).
17. Ahuja, N. & Issa, J.P. Aging, methylation and cancer. Histol. Histopathol. 15, 835-842 (2000).
18. Baylin, S. & Bestor, T.H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1, 299-305 (2002).
19. Rush, L.J. & Plass, C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal. Biochem. 307, 191-201 (2002).
20. Smiraglia, D.J. & Plass, C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 21, 5414-5426 (2002).
21. Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37, 853-862 (2005).
22. Mukhopadhyay, R. et al. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res. 14, 1594-1602 (2004).
23. Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307-2312 (1999).
24. Stirzaker, C., Song, J.Z., Davidson, B. & Clark, S.J. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64, 3871-3877 (2004).
25. Maruyama, R. et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 8, 514-519 (2002).
26. Odom, D.T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378-1381 (2004).
27. Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141-149 (2002).
28. Segal, E., Yelensky, R. & Koller, D. Genome-wide discovery of transcriptional modules from DNA sequence and gene expression. Bioinformatics 19 (Suppl.), i273-i282 (2003).
29. Su, A.I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062-6067 (2004).
30. Notterman, D.A., Alon, U., Sierk, A.J. & Levine, A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61, 3124-3130 (2001).
31. Esteller, M. et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007 (2001).
32. Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082 (2002).
33. Feltus, F.A., Lee, E.K., Costello, J.F., Plass, C. & Vertino, P.M. Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA 100, 12253-12258 (2003).
34. Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629 (2002).
35. Cao, R. & Zhang, Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14, 155-164 (2004).
36. Plath, K. et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135 (2003).
37. Silva, J. et al. Establishment of histone H3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev. Cell 4, 481-495 (2003).
38. Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature advance online publication 14 December 2005 (doi:10.1038/nature04431).
39. Eden, S., Hashimshony, T., Keshet, I., Thorne, A.W. & Cedar, H. DNA methylation models histone acetylation. Nature 394, 842-843 (1998).